期刊
BIOMARKERS IN MEDICINE
卷 15, 期 14, 页码 1201-1210出版社
FUTURE MEDICINE LTD
DOI: 10.2217/bmm-2020-0656
关键词
(TIMP-2)*(IGFBP7); acute kidney injury; AKI; cardiac surgery
The study evaluated the use of urinary (TIMP-2)*(IGFBP7) for preventing acute kidney injury in patients undergoing elective cardiac surgery. The intervention cohort receiving renal supportive measures based on (TIMP-2)*(IGFBP7) values had a significantly lower incidence of AKI compared to the control group who received standard supportive care. The results suggest that renal supporting care guided by the urinary biomarkers could reduce the risk of AKI development.
Aim: The purpose of this study was to assess urinary (TIMP-2)*(IGFBP7) for prevention of acute kidney injury (AKI) in patients undergoing elective cardiac surgery. Materials & methods: Two retrospective cohorts were analyzed before and after the implementation of urinary (TIMP-2)*(IGFBP7). The control cohort had a standard supportive care. For the (TIMP-2)*(IGFBP7) cohort, patients with the (TIMP-2)*(IGFBP7) >0.3 received renal supportive measures. Results: A total of 382 patients were included, 197 in the control cohort and 185 in intervention cohort. The incidence of AKI was significantly reduced in the (TIMP-2)*(IGFBP7) cohort (20.5 vs 29.9%, p < 0.05). In multivariate analysis, patients of the (TIMP-2)*(IGFBP7) cohort had a lower risk of developing AKI (p = 0.029). Conclusion: In conclusion, renal supporting care based on AKI risk stratification using urinary (TIMP-2)*(IGFBP7) may reduce AKI incidence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据